Natera Inc Stock Today

NTRA Stock  USD 148.22  5.71  4.01%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
Natera is trading at 148.22 as of the 17th of March 2025, a 4.01 percent increase since the beginning of the trading day. The stock's open price was 142.51. Natera has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Note, on December 6, 2024, Representative Josh Gottheimer of US Congress acquired under $15k worth of Natera Inc's common stock.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
2nd of July 2015
Category
Healthcare
Classification
Health Care
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. Natera, Inc. was founded in 2003 and is based in Austin, Texas. Natera operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. The company has 135.19 M outstanding shares of which 2.49 M shares are now shorted by private and institutional investors with about 1.63 trading days to cover. More on Natera Inc

Moving together with Natera Stock

  0.7EVO Evotec SE ADRPairCorr

Moving against Natera Stock

  0.59IVA Inventiva SaPairCorr
  0.53KRYS Krystal BiotechPairCorr
  0.43PBH Prestige Brand HoldingsPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Natera Stock Highlights

ESG Sustainability
Environmental
Governance
Social
CEO DirectorSteven Chapman
Thematic IdeaHealthcare (View all Themes)
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, ARCA Biotechnology, NASDAQ Composite, NASDAQ Health Care, NASDAQ Composite Total, Healthcare, Health Care, Biotechnology, Diagnostics & Research, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.941.0218
Significantly Down
Slightly volatile
Gross Profit Margin0.340.603
Way Down
Slightly volatile
Total Current Liabilities181.8 M344 M
Way Down
Slightly volatile
Non Current Liabilities Total229 M121.3 M
Way Up
Slightly volatile
Total Assets1.7 B1.7 B
Sufficiently Up
Slightly volatile
Total Current Assets1.4 B1.4 B
Sufficiently Up
Slightly volatile
Debt Levels
Natera can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Natera's financial leverage. It provides some insight into what part of Natera's total assets is financed by creditors.
Liquidity
Natera Inc currently holds 187.12 M in liabilities with Debt to Equity (D/E) ratio of 0.9, which is about average as compared to similar companies. Natera Inc has a current ratio of 3.51, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Natera's use of debt, we should always consider it together with its cash and equity.

Sale Purchase Of Stock

17.43 Million
Natera Inc (NTRA) is traded on NASDAQ Exchange in USA. It is located in 13011 McCallen Pass, Austin, TX, United States, 78753 and employs 4,424 people. Natera is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 20.04 B. Natera Inc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 135.19 M outstanding shares of which 2.49 M shares are now shorted by private and institutional investors with about 1.63 trading days to cover. Natera Inc currently holds about 638.65 M in cash with 135.66 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.59.
Check Natera Probability Of Bankruptcy
Ownership Allocation
Natera Inc maintains a total of 135.19 Million outstanding shares. The majority of Natera outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Natera Inc to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Natera Inc. Please pay attention to any change in the institutional holdings of Natera as this could imply that something significant has changed or is about to change at the company. On December 6, 2024, Representative Josh Gottheimer of US Congress acquired under $15k worth of Natera Inc's common stock.
Check Natera Ownership Details

Natera Stock Institutional Holders

InstituionRecorded OnShares
Geode Capital Management, Llc2024-12-31
2.2 M
Kynam Capital Management, Lp2024-12-31
M
Ameriprise Financial Inc2024-12-31
M
Amvescap Plc.2024-12-31
1.8 M
Goldman Sachs Group Inc2024-12-31
1.7 M
Sofinnova Ventures2024-12-31
1.6 M
Franklin Resources Inc2024-12-31
1.5 M
Fmr Inc2024-12-31
1.5 M
Lord, Abbett & Co Llc2024-12-31
1.4 M
Vanguard Group Inc2024-12-31
12.3 M
Blackrock Inc2024-12-31
9.2 M
View Natera Diagnostics

Natera Historical Income Statement

At present, Natera's Depreciation And Amortization is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 883.4 M, whereas Operating Income is forecasted to decline to (233.4 M). View More Fundamentals

Natera Stock Against Markets

Natera Corporate Management

Michael MBAChief OfficerProfile
Olesya CPAChief OfficerProfile
LLM LLMS OfficerProfile
Jonathan MEngCoFounder DirectorProfile
Sheetal ParmarHead ServicesProfile
Rishi KackerChief OfficerProfile
Phil GrinnellVice SalesProfile
When determining whether Natera Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Natera's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Natera Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Natera Inc Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Natera Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Natera. If investors know Natera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Natera listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.53)
Revenue Per Share
13.606
Quarterly Revenue Growth
0.53
Return On Assets
(0.09)
Return On Equity
(0.19)
The market value of Natera Inc is measured differently than its book value, which is the value of Natera that is recorded on the company's balance sheet. Investors also form their own opinion of Natera's value that differs from its market value or its book value, called intrinsic value, which is Natera's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Natera's market value can be influenced by many factors that don't directly affect Natera's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Natera's value and its price as these two are different measures arrived at by different means. Investors typically determine if Natera is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Natera's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.